Travis H. Bird
EUCYT™ Founder and CEO
Travis H. Bird, founder and CEO of EUCYT™, developed the company after realizing the importance of finding alternative ways to help heal concerns such as tendon, joint, cartilage, and muscle injuries and chronic issues such as diabetes using stem cell solutions. He’s a 23-year veteran in the medical industry and is dedicated to maintaining EUCYT’s reputation built on quality, service and uncompromising ethics.
Bird received his Bachelor of Science from the University of Mary, Bismarck, ND, and continued his medical training at Mayo Clinic Medical School of Medicine and Science in Rochester, MN. He became highly interested in stem-cell therapies after studying the ways they could bring relief to patients.
EUCYT is poised to work one-on-one with clients to evaluate problems and create individual care plans. This allows physicians and health networks to expand and improve treatment plans that move beyond the approach of surgical and pill-based care.
“It’s possible everyone is a potential candidate for stem-cell treatment sometime in their life,” Bird said. “What makes EUCYT unique is the diversity of our product lines. We focus on specific diseases with specific cells instead of today’s current ‘one pill fits all’ approach.”
Lonnie R. Empey, DO, FACP
EUCYT™ Medical Director
Lonnie R. Empey, DO, FACP, EUCYT Labs’ medical director, is a board-certified internal medicine physician and Fellow of the American College of Physicians. He currently is vice chief of staff at Desert Springs Hospital and a practicing hospitalist. He also serves as an adjunct clinical professor with the University of Nevada School of Medicine and Touro University Nevada.
As EUCYT’s medical director, Empey feels regenerative medicine, also known as stem-cell therapies, are key to the future of medicine.
“Every generation can benefit from EUCYT’s regenerative medicine solutions. I am confident that it is the greatest opportunity for curing chronic diseases such as diabetes as well as joint, ligament, muscle and tendon issues. As a board-certified internal medicine physician with more than 25 years of experience, I have come to realize the current chronic-care treatment model has been designed to treat, but not cure, chronic diseases and injuries. Patients deserve better. It’s time for stem-cell cures.”
Dr. Roddy McGee, DO
EUCYT™ Board Member
Dr. Roddy McGee is a Las Vegas orthopedic surgeon with more than seven years of orthopedic surgical and teaching experience. His experience includes serving an orthopedic residency as attending physician for Valley Hospital Medical Center in Las Vegas, associate professor of orthopedic surgery at Touro University, Nevada, and as an article reviewer of the American Journal of Sports Medicine.
McGee’s practice focus is sports medicine which makes him a perfect fit for stem cell treatments and the solutions offered to athletes by EUCYT Labs. His current research interests include:
- Return to Play after ACL and other sports injuries
- Orthobiologics in sports medicine (stem cell/PRP for nonoperative treatment and as an augment to surgical procedures)
- Return to performance metrics after injury
- Reintegration to sport progressions
- Augmented grafts in ACL and other ligament surgeries